TY  - GEN
AU  - Carella,A M
TI  - Hypothesis: upfront use of ABL kinase inhibitor combination, either simultaneously or sequentially, in high-risk Ph+ leukemias?
SN  - 1432-0584
PY  - 2010///0427
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Drug Administration Schedule
KW  - Humans
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Models, Theoretical
KW  - Neoadjuvant Therapy
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Proto-Oncogene Proteins c-abl
KW  - antagonists & inhibitors
KW  - Risk Factors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s00277-010-0907-3
ER  -